Janux Therapeutics (JANX) Receivables - Other (2023 - 2025)
Historic Receivables - Other for Janux Therapeutics (JANX) over the last 3 years, with Q3 2025 value amounting to $6.3 million.
- Janux Therapeutics' Receivables - Other rose 4178.27% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 4178.27%. This contributed to the annual value of $5.4 million for FY2024, which is 14900.51% up from last year.
- As of Q3 2025, Janux Therapeutics' Receivables - Other stood at $6.3 million, which was up 4178.27% from $5.7 million recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Receivables - Other ranged from a high of $6.3 million in Q3 2025 and a low of $2.2 million during Q4 2023
- Its 3-year average for Receivables - Other is $4.8 million, with a median of $5.0 million in 2024.
- As far as peak fluctuations go, Janux Therapeutics' Receivables - Other surged by 14900.51% in 2024, and later surged by 2491.22% in 2025.
- Janux Therapeutics' Receivables - Other (Quarter) stood at $2.2 million in 2023, then soared by 149.01% to $5.4 million in 2024, then rose by 17.36% to $6.3 million in 2025.
- Its Receivables - Other was $6.3 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.6 million in Q1 2025.